Page last updated: 2024-09-05

palmarumycin cp(1) and Neoplasms

palmarumycin cp(1) has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burke-Gaffney, A; Callister, ME; Nakamura, H1
Birmingham, A; Kirkpatrick, DL; Lynch, SM; Powis, G; Wipf, P1

Reviews

1 review(s) available for palmarumycin cp(1) and Neoplasms

ArticleYear
Thioredoxin: friend or foe in human disease?
    Trends in pharmacological sciences, 2005, Volume: 26, Issue:8

    Topics: Cardiovascular Diseases; Dioxanes; Humans; Molecular Structure; Naphthalenes; Neoplasms; Pyridazines; Spiro Compounds; Thioredoxins; Triazoles

2005

Other Studies

1 other study(ies) available for palmarumycin cp(1) and Neoplasms

ArticleYear
Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dioxanes; Enzyme Inhibitors; Glycine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Naphthalenes; Neoplasms; Spiro Compounds; Thioredoxin Reductase 1; Thioredoxin-Disulfide Reductase; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2006